UA56814U - Method for assessing efficacy of nisoldipine for treatment of ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic-type impairment of diastolic function of left ventricle
- Google Patents
Method for assessing efficacy of nisoldipine for treatment of ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic-type impairment of diastolic function of left ventricle
Государственное Высшее Учебное Заведение "Ужгородский Национальный Университет"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное Высшее Учебное Заведение "Ужгородский Национальный Университет"filedCriticalГосударственное Высшее Учебное Заведение "Ужгородский Национальный Университет"
Priority to UAU201008955UpriorityCriticalpatent/UA56814U/en
Publication of UA56814UpublicationCriticalpatent/UA56814U/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
A method for assessing the efficacy of Nisoldipine for the treatment of the ischemic heart disease with angina pectoris and arterial hypertension with the hypertrophic-type impairment of diastolic function of the left ventricle provides for comparing the state of the patients prior to and after treatment. Prior to the treatment, Doppler echocardiography is performed, transmitral blood flow is assessed by measuring the rate of the early diastolic filling. The same parameters are assessed after the treatment. When the rate of the early diastolic filling of the left ventricle increase by at least 15 % as compared with that prior to the treatment, hemodynamic result and antianginal effect are considered as positive ones.
UAU201008955U2010-07-192010-07-19Method for assessing efficacy of nisoldipine for treatment of ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic-type impairment of diastolic function of left ventricle
UA56814U
(en)
Method for assessing efficacy of nisoldipine for treatment of ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic-type impairment of diastolic function of left ventricle
Method for assessing efficacy of nisoldipine for treatment of ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic-type impairment of diastolic function of left ventricle
Method for assessing efficacy of nisoldipine for treatment of ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic-type impairment of diastolic function of left ventricle
Method for assessing efficacy of nisoldipine for treatment of ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic-type impairment of diastolic function of left ventricle
Method for assessment of treatment efficacy in patients with ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic type impairment of diastolic function of left ventricle
Method for assessing efficacy of amlodipin in treatment of ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic type of impairment of diastolic function of left ventricle
Method for assessing efficacy of felodipine in treatment of ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic type of impairment of diastolic function of left ventricle
Method for assessing efficacy of lovastatin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
Method for assessing efficacy of simvastatin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
Method for assessment of pitavastatin efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to "hypertrophic" type
Method for assessment of irbesartan efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to "hypertrophic" type
Method for assessment of olmesartan efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
Method for assessing efficacy of ivabradin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
Method for assessing efficacy of cilasapril treatment in patients with ischemic heart disease, angina and arterial hypertension with impaired diastolic function of left ventricle of 'hypertrophic' type
Method for assessment of azilsartan efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of the ventricle according to "hypertrophic" type
Method for assessing efficacy of barnidipin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
Method for assessing efficacy of pravastatin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
Method for assessing efficacy of oxprenolol treatment in patients with ischemic heart disease, cardiac angina and arterial hypertension with impaired diastolic function of left ventricle of 'hypertrophic' type
Method for assessing efficacy of celiprolol treatment in patients with ischemic heart disease, cardiac angina and arterial hypertension with impaired diastolic function of left ventricle of 'hypertrophic' type
Method for assessing efficacy of isosorbid mononitrate in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
Method for assessment of fenofibrate efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to "hypertrophic" type
Method for assessing efficacy of treating patients with ischemic heart disease and angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
Method for assessing efficacy of rozuvastatin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
method for evaluating of treatment effectiveness of patients with ischemic heart disease and angina pectoris, and hypertension with diastolic impairment of the left ventricle by 'hypertrophy' type
Method for assessing efficacy of azelnidipin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
method for evaluating the effectiveness of treatment with MOEXOPRIL of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
method for evaluating the effectiveness of treatment with clintiazem of patients with ischemia with angina pectoris and arterial hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
method for evaluating the effectiveness of treatment with trimetazidine of patients with ischemic heart disease with angina pectoris and arterial hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type